XML 103 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity Compensation Plans and Share-Based Compensation - Restricted Stock Unit Award Activity (Details) - $ / shares
shares in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Outstanding at beginning of year   373 357 254
Underlying Shares - Outstanding at end of year 373 383 373 357
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Outstanding at beginning of year   $ 77.40 $ 69.13 $ 59.53
Weighted-Average Exercise Price - Outstanding at end of year $ 77.40 $ 71.93 $ 77.40 $ 69.13
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   105 238 109
Underlying Shares - Exercised   (91) (117) (10)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 58.68 $ 78.40 $ 86.86
Weighted-Average Exercise Price - Vested   $ 72.70 $ 48.25 $ 45.93
Vesting period   3 years    
Time Based Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   48 21 19
Underlying Shares - Exercised   (19) (12) (15)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 58.68 $ 84.93 $ 86.86
Weighted-Average Exercise Price - Vested   $ 67.86 $ 76.84 $ 73.78
Performance-Based Canceled        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Exercised   (18) (114) 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Vested   $ 72.56 $ 84.93 $ 0
Grant date fair value of replacement performance-based awards $ 72.37      
Time Based Canceled        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Exercised   (15) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Vested   $ 72.49 $ 0 $ 0